期刊
CHEMBIOCHEM
卷 8, 期 14, 页码 1679-1687出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.200700154
关键词
-
资金
- NCRR NIH HHS [C06 RR-16572] Funding Source: Medline
- NIA NIH HHS [AG15408, AG20245] Funding Source: Medline
A group of styryl-based neutral compounds has been synthesized in this study for potential use as in vivo imaging agents for beta-amyloid plaques. Of 56 candidates, 14 compounds were found to label beta-amyloid plaques well on Alzheimer's disease (AD) human brain sections in vitro. The binding affinity to beta-amyloid fibrils was then determined by measuring the change in fluorescence intensity. Interestingly, we found that a class of quinaldine-styryl scaffold compounds displays specific binding to beta-amyloid fibrils. A representative compound, STB-8, was used in ex vivo and in vivo imaging experiments on an AD transgenic mouse model and demonstrated excellent blood-brain barrier (BBB) permeability and specific staining of the AD beta-amyloid plaques.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据